With millions vaccinated, rare side-effects of jabs are emerging
Johnson & Johnson’s vaccine is the latest to suffer a setback
CHRIS WHITTY, England’s chief medical officer, vividly recalls a nerve-racking moment on December 8th 2020. That was the day when England became the first country to roll out a covid-19 vaccine, a jab developed by Pfizer and BioNTech. Near midnight on vaccination day one “We were discussing it and just thinking ‘What are we dealing with here? These are small numbers and we’ve already had several dangerous near misses’,” said Dr Whitty in a recent talk at the Royal Society of Medicine. In some people, it had turned out, the vaccine sets off anaphylaxis, a life-threatening allergic reaction. But this is rare. It occurred just once among the 22,000 or so people vaccinated in the trial, which could have been by chance. Now, with hundreds of millions vaccinated, the rate at which it occurs is clearer: five per million.
This article appeared in the Science & technology section of the print edition under the headline “Sorting signal from noise”
More from Science & technology
Wasps stole genes from viruses
That probably assisted their evolutionary diversification
America’s departure from the WHO would harm everyone
Whether it is a negotiating ploy remains to be seen
Genetic engineering could help rid Australia of toxic cane toads
It is better than freezing them to death
High-tech antidotes for snake bites
Genetic engineering and AI are powering the search for antivenins
Can you breathe stress away?
Scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship